Unité Mixte de Recherche (UMR) S872, Centre de Recherche des Cordeliers, 15 rue de l'Ecole de médecine, Paris, F-75006 France.
Am J Physiol Endocrinol Metab. 2010 May;298(5):E1078-87. doi: 10.1152/ajpendo.00737.2009. Epub 2010 Feb 23.
The sugar transporter GLUT2, present in several tissues of the gut-brain axis, has been reported to be involved in the control of food intake. GLUT2 is a sugar transporter sustaining energy production in the cell, but it can also function as a receptor for extracellular glucose. A glucose-signaling pathway is indeed triggered, independently of glucose metabolism, through its large cytoplasmic loop domain. However, the contribution of the receptor function over the transporter function of GLUT2 in the control of food intake remains to be determined. Thus, we generated transgenic mice that express a GLUT2-loop domain, blocking the detection of glucose but leaving GLUT2-dependent glucose transport unaffected. Inhibiting GLUT2-mediated glucose detection augmented daily food intake by a mechanism that increased the meal size but not the number of meals. Peripheral hormones (ghrelin, insulin, leptin) were unaffected, leading to a focus on central aspects of feeding behavior. We found defects in c-Fos activation by glucose in the arcuate nucleus and changes in the amounts of TRH and orexin neuropeptide mRNA, which are relevant to poorly controlled meal size. Our data provide evidence that glucose detection by GLUT2 contributes to the control of food intake by the hypothalamus. The sugar transporter receptor, i.e., "transceptor" GLUT2, may constitute a drug target to treat eating disorders and associated metabolic diseases, particularly by modulating its receptor function without affecting vital sugar provision by its transporter function.
肠道-脑轴中存在多种组织的糖转运蛋白 GLUT2 已被报道参与食物摄入的控制。GLUT2 是一种维持细胞能量产生的糖转运蛋白,但它也可以作为细胞外葡萄糖的受体发挥作用。确实存在一条葡萄糖信号通路,通过其大的细胞质环结构域,独立于葡萄糖代谢而被触发。然而,GLUT2 在控制食物摄入方面的受体功能相对于转运功能的贡献仍有待确定。因此,我们生成了表达 GLUT2 环结构域的转基因小鼠,该结构域阻断了葡萄糖的检测,但不影响 GLUT2 依赖性葡萄糖转运。抑制 GLUT2 介导的葡萄糖检测通过增加餐量但不增加餐数的机制增加了每日食物摄入量。外周激素(ghrelin、胰岛素、瘦素)不受影响,导致人们关注摄食行为的中枢方面。我们发现,葡萄糖在弓状核中的 c-Fos 激活存在缺陷,并且涉及难以控制的进餐量的 TRH 和食欲素神经肽 mRNA 的含量发生变化。我们的数据提供了证据表明,GLUT2 通过检测葡萄糖来促进下丘脑对食物摄入的控制。糖转运蛋白受体,即“转受体”GLUT2,可能成为治疗进食障碍和相关代谢疾病的药物靶点,特别是通过调节其受体功能而不影响其转运功能对重要糖供应的影响。